10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001564590-21-004092`
Period End Date	20201231
Filing Date	20210203
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	tyme-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 57 Cash Flow Statement 46 Stockholders Equity 35

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.49M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.70M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$1.43M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$396.96K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$981.95K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$270.56K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.08M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.19M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.18K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.29K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$530.99K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$84.24K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$150.30K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total assets	`Assets`	$29.50M	USD	Point-in-time
Total assets	`Assets`	$15.81M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts payable and other current liabilities (including $84,000 and $73,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.83M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	123.31M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	130.17M	shares	Point-in-time
Accounts payable and other current liabilities (including $84,000 and $73,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.00M	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$398.20K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	130.17M	shares	Point-in-time
Severance payable	`SeverancePayableCurrent`	$380.72K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.80M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.18M	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$518.12K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$54.66K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$33.87K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.61M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.25M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$960.13K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$51.81K	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$3.64M	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$1.02M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.64M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.48M	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 130,172,441 issued and outstanding at December 31, 2020, 300,000,000 authorized, 123,312,252 issued and outstanding at March 31, 2020	`CommonStockValue`	$12.33K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 130,172,441 issued and outstanding at December 31, 2020, 300,000,000 authorized, 123,312,252 issued and outstanding at March 31, 2020	`CommonStockValue`	$13.02K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$138.76M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$126.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-107.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-129.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.03M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.17M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$2.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.31M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$15.81M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$29.50M	USD	Point-in-time

Income Statement 57 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$58.50K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$109.00K	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$307.00K	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$450.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$9.37M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$12.97M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.46M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.55M	USD	1 Quarter
General and administrative (including $109,000, $58,500, $450,000 and $307,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$9.60M	USD	3 Qtrs
General and administrative (including $109,000, $58,500, $450,000 and $307,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.08M	USD	1 Quarter
General and administrative (including $109,000, $58,500, $450,000 and $307,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.32M	USD	1 Quarter
General and administrative (including $109,000, $58,500, $450,000 and $307,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$7.99M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$18.97M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$6.54M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.87M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$20.96M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.87M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-18.97M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.54M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-20.96M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.59M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$425.80K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$228.75K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.00M	USD	3 Qtrs
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$185.75K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$19.06K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$38.26K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.54K	USD	1 Quarter
Interest expense	`InterestExpense`	$26.31K	USD	1 Quarter
Interest expense	`InterestExpense`	$77.89K	USD	3 Qtrs
Interest expense	`InterestExpense`	$22.54K	USD	1 Quarter
Interest expense	`InterestExpense`	$88.53K	USD	3 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$-832.59K	USD	3 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$-249.75K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$2.69M	USD	3 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$-413.85K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.80M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-16.28M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.96M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.17	USD	3 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	3 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	130.17M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	111.96M	shares	3 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	112.07M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	127.61M	shares	3 Qtrs

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-16.28M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-21.80M	USD	3 Qtrs
Depreciation	`Depreciation`	$3.89K	USD	3 Qtrs
Depreciation	`Depreciation`	$3.89K	USD	3 Qtrs
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$2.74M	USD	3 Qtrs
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$4.67M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.59M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$425.80K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$228.75K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.00M	USD	3 Qtrs
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	3 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$301.76K	USD	3 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-121.30K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-708.10K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-711.39K	USD	3 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-218.42K	USD	3 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-141.50K	USD	3 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-157.04K	USD	3 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$175.23K	USD	3 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-277.30K	USD	3 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-330.47K	USD	3 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-193.89K	USD	3 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-623.47K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-34.94K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-44.42K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.50M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.86M	USD	3 Qtrs
Insurance note payments	`InsuranceNotePayments`	$518.12K	USD	3 Qtrs
Insurance note payments	`InsuranceNotePayments`	$597.34K	USD	3 Qtrs
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$5.81M	USD	3 Qtrs
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$11.62M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$11.02M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.29M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.84M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-13.21M	USD	3 Qtrs
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.47M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.49M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.30M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.47M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.49M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.30M	USD	Point-in-time
Interest	`InterestPaidNet`	$88.53K	USD	3 Qtrs
Interest	`InterestPaidNet`	$77.89K	USD	3 Qtrs
Operating lease right-of-use asset obtained in exchange for lease liabilities.	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$75.44K	USD	3 Qtrs

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$14.50M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$9.17M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$2.40M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$7.31M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	130.17M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time
Warrant to share exchange	`StockIssuedDuringPeriodValueWarrantToShareExchange`	$3.39M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.45M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.62M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.60M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.07M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$883.93K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$784.89K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.80M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-16.28M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.96M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$14.50M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$9.17M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$2.40M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$7.31M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	130.17M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.